Loading...
BioMarin Pharmaceutical Inc.
BMRN•NASDAQ
Healthcare
Biotechnology
$59.01
$-0.75(-1.26%)
BioMarin Pharmaceutical Inc. (BMRN) Financial Performance & Income Statement Overview
Review BioMarin Pharmaceutical Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
17.97%
↑ 17.97%
Operating Income Growth
149.03%
↑ 149.03%
Net Income Growth
154.62%
↑ 154.62%
Operating Cash Flow Growth
259.69%
↑ 259.69%
Operating Margin
20.51%
↑ 20.51%
Gross Margin
78.86%
↑ 78.86%
Net Profit Margin
17.83%
↑ 17.83%
ROE
9.46%
↑ 9.46%
ROIC
9.24%
↑ 9.24%
BioMarin Pharmaceutical Inc. (BMRN) Income Statement & Financial Overview
Review BioMarin Pharmaceutical Inc.'s (BMRN) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $747.31M | $745.74M | $708.66M | $648.83M |
| Cost of Revenue | $136.14M | $188.46M | $144.76M | $139.48M |
| Gross Profit | $611.17M | $557.28M | $563.90M | $509.36M |
| Gross Profit Ratio | $0.82 | $0.75 | $0.80 | $0.79 |
| R&D Expenses | $173.51M | $184.90M | $183.79M | $204.99M |
| SG&A Expenses | $266.61M | $253.48M | $276.65M | $222.51M |
| Operating Expenses | $449.77M | $443.39M | $460.44M | $427.49M |
| Total Costs & Expenses | $585.91M | $631.85M | $605.20M | $566.97M |
| Interest Income | $17.68M | $18.05M | $19.79M | $19.36M |
| Interest Expense | $2.58M | $2.97M | $3.57M | $3.55M |
| Depreciation & Amortization | $23.61M | $19.006M | $26.46M | $27.35M |
| EBITDA | $195.82M | $156.41M | $162.17M | $136.44M |
| EBITDA Ratio | $0.26 | $0.21 | $0.23 | $0.21 |
| Operating Income | $161.41M | $113.89M | $103.46M | $81.86M |
| Operating Income Ratio | $0.22 | $0.15 | $0.15 | $0.13 |
| Other Income/Expenses (Net) | $8.23M | $20.55M | $11.68M | $17.09M |
| Income Before Tax | $169.64M | $134.44M | $132.14M | $105.55M |
| Income Before Tax Ratio | $0.23 | $0.18 | $0.19 | $0.16 |
| Income Tax Expense | $44.70M | $28.36M | $24.96M | $16.89M |
| Net Income | $124.94M | $106.08M | $107.17M | $88.66M |
| Net Income Ratio | $0.17 | $0.14 | $0.15 | $0.14 |
| EPS | $0.65 | $0.57 | $0.56 | $0.47 |
| Diluted EPS | $0.63 | $0.55 | $0.55 | $0.44 |
| Weighted Avg Shares Outstanding | $190.69M | $190.43M | $190.11M | $188.87M |
| Weighted Avg Shares Outstanding (Diluted) | $196.58M | $197.15M | $200.50M | $199.26M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan